BRAF and cancer: In the histology samples of the indeterminate nodules, 48 (47.5%) were mutated, being two benign lesions with RAS mutation and in 46 malignant tumors, of which 11 (14.5%) were found to have TERTp mutation, 13 (16.9%) had BRAF, and 22 (29.3%) had RAS mutation.